YMAB
Y-Mabs Therapeutics Inc

697
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 06,
Pre-Market

Estimated EPS

-$0.22

Estimated Rev

$20.91M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.22
--
--
N/A
Q2 '25
-$0.26
-$0.07
73.38%
BEAT
Q1 '25
-$0.21
-$0.12
43.46%
BEAT
Q4 '24
-$0.09
-$0.15
-62.79%
MISSED
Q3 '24
-$0.16
-$0.16
-1.39%
MISSED

Latest YMAB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.